ZFIN ID: ZDB-PUB-150120-3
CLPB Mutations Cause 3-Methylglutaconic Aciduria, Progressive Brain Atrophy, Intellectual Disability, Congenital Neutropenia, Cataracts, Movement Disorder
Wortmann, S.B., Zitkiewicz, S., Kousi, M., Szklarczyk, R., Haack, T.B., Gersting, S.W., Muntau, A.C., Rakovic, A., Renkema, G.H., Rodenburg, R.J., Strom, T.M., Meitinger, T., Rubio-Gozalbo, M.E., Chrusciel, E., Distelmaier, F., Golzio, C., Jansen, J.H., van Karnebeek, C., Lillquist, Y., Lücke, T., Õunap, K., Zordania, R., Yaplito-Lee, J., van Bokhoven, H., Spelbrink, J.N., Vaz, F.M., Pras-Raves, M., Ploski, R., Pronicka, E., Klein, C., Willemsen, M.A., de Brouwer, A.P., Prokisch, H., Katsanis, N., Wevers, R.A.
Date: 2015
Source: American journal of human genetics   96(2): 245-57 (Journal)
Registered Authors: Katsanis, Nicholas
Keywords: none
MeSH Terms:
  • Abnormalities, Multiple/genetics*
  • Abnormalities, Multiple/pathology
  • Adenosine Triphosphatases/metabolism
  • Animals
  • Atrophy/genetics
  • Atrophy/pathology
  • Base Sequence
  • Brain/pathology*
  • Cataract/genetics
  • Cataract/pathology
  • Endopeptidase Clp/genetics*
  • Endopeptidase Clp/metabolism
  • Exome/genetics
  • Humans
  • Intellectual Disability/genetics*
  • Intellectual Disability/pathology
  • Metabolism, Inborn Errors/genetics*
  • Metabolism, Inborn Errors/pathology
  • Molecular Sequence Data
  • Movement Disorders/genetics
  • Movement Disorders/pathology
  • Neutropenia/genetics
  • Neutropenia/pathology
  • Polymorphism, Single Nucleotide/genetics
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism
  • Sequence Analysis, DNA
  • Zebrafish
PubMed: 25597510 Full text @ Am. J. Hum. Genet.
We studied a group of individuals with elevated urinary excretion of 3-methylglutaconic acid, neutropenia that can develop into leukemia, a neurological phenotype ranging from nonprogressive intellectual disability to a prenatal encephalopathy with progressive brain atrophy, movement disorder, cataracts, and early death. Exome sequencing of two unrelated individuals and subsequent Sanger sequencing of 16 individuals with an overlapping phenotype identified a total of 14 rare, predicted deleterious alleles in CLPB in 14 individuals from 9 unrelated families. CLPB encodes caseinolytic peptidase B homolog ClpB, a member of the AAA+ protein family. To evaluate the relevance of CLPB in the pathogenesis of this syndrome, we developed a zebrafish model and an in vitro assay to measure ATPase activity. Suppression of clpb in zebrafish embryos induced a central nervous system phenotype that was consistent with cerebellar and cerebral atrophy that could be rescued by wild-type, but not mutant, human CLPB mRNA. Consistent with these data, the loss-of-function effect of one of the identified variants (c.1222A>G [p.Arg408Gly]) was supported further by in vitro evidence with the mutant peptides abolishing ATPase function. Additionally, we show that CLPB interacts biochemically with ATP2A2, known to be involved in apoptotic processes in severe congenital neutropenia (SCN) 3 (Kostmann disease [caused by HAX1 mutations]). Taken together, mutations in CLPB define a syndrome with intellectual disability, congenital neutropenia, progressive brain atrophy, movement disorder, cataracts, and 3-methylglutaconic aciduria.